Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up - sprookjes - yvandenbroek - TriplyDB

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up

http://www.wikidata.org/entity/Q35449751

about

[Epilepsy-associated tumors of the central nervous system: Epilepsy surgery and oncological aspects].BRAF Mutation is Associated with an Improved Survival in Glioma-a Systematic Review and Meta-analysis.Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults.Pilocytic astrocytoma: pathology, molecular mechanisms and markers.Glioma Subclassifications and Their Clinical Significance.Molecular pathology of paediatric central nervous system tumours.The new WHO 2016 classification of brain tumors-what neurosurgeons need to know.Clinical, Imaging, Histopathological and Molecular Characterization of Anaplastic Ganglioglioma.Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.Rare Primary Central Nervous System Tumors Encountered in Pediatrics.Pleomorphic Carcinoma of the Colon: Morphological and Immunohistochemical Findings.Impact of WHO 2016 update of brain tumor classification, molecular markers and clinical outcomes in pleomorphic xanthoastrocytoma.Dabrafenib in BRAFV600-mutated anaplastic pleomorphic xanthoastrocytoma.Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation.Cytologic features of pleomorphic xanthoastrocytoma, WHO grade II. A comparative study with glioblastoma.[Alterations in the WHO classification of brain tumors from 2016].Dabrafenib and trametinib in BRAFV600E mutated glioma.A case of high-grade astrocytoma with BRAF and ATRX mutations following a long-standing course over two decades.Pleomorphic Xanthoastrocytoma; Clinicopathological spectrum of An Intriguing neoplasm.BRAF inhibition with concomitant tumor treating fields for a multiply progressive pleomorphic xanthoastrocytoma.Diagnostic accuracy of diffusion weighted imaging for differentiation of supratentorial pilocytic astrocytoma and pleomorphic xanthoastrocytoma.BRAF activating mutations involving the β3-αC loop in V600E-negative anaplastic pleomorphic xanthoastrocytoma.Pleomorphic xanthoastrocytomas of adults: MRI features, molecular markers, and clinical outcomes

P2860

Q31032523-EFCA5E96-F5B9-4E3E-80D1-F45EB2C33F5D Q36378426-B1DE3A01-A1DC-41BC-8615-C67ABB119F9F Q38379237-424CAA1F-C4E4-47A9-8FA6-FF1AE613B4F4 Q38384754-742DB510-7356-4B12-8FA1-521E0F54016D Q38747746-D239EDE4-E329-4269-8A9F-4391F1C28C1A Q38971961-29C6B856-93CE-413C-BF26-BFBCFF52591F Q39091307-DE30FF6D-B269-4494-9DD6-B88BB5D66F39 Q39475786-7ABFEB08-4B91-45BB-83A5-243FFF7B9F78 Q40857380-7345A858-78C9-4541-BE91-1F7E9052DBB5 Q41646521-EC8FFEC5-880E-48D9-9F02-6956FA7F256A Q41866925-5A444301-69CD-4F23-831F-92072BEAF89B Q47581117-896E9700-7A4D-4000-99A7-30538EEDE858 Q47967869-7B87677F-C641-4D60-AF21-E950E8C3B57C Q48258617-B979A9CC-ABDD-4023-B779-909F3316E2B1 Q48358833-66664B58-B1A8-45C2-A086-C619A9D40981 Q48517514-B1EF1413-9270-44D4-B744-15D01A49132C Q49565156-39B10DA3-DD75-4515-8B1F-8A51D60B9C35 Q53514539-B2296D48-64C5-4204-B3B7-A8DFDFD29048 Q54506430-6D81ABCF-8B4D-42F2-B6C8-C8B48E50EE55 Q55052167-8F1FF982-AF88-41C6-9556-8CE2CDBECE3D Q55273318-7276FB63-4E6E-4B87-98A6-409C593CDF07 Q55375871-B43B76E6-EFD5-4581-A966-A5A1623A6CF6 Q58700366-496EF644-B05A-4B2E-8EC5-0D46E7D3F5A6

P2860

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up

http://www.wikidata.org/entity/Q35449751

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up

@ast

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up

@en

type

label

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up

@ast

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up

@en

prefLabel

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up

@ast

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up

@en

P1433

Q35449751-6A797725-0BF3-4239-8D22-E035DD10D555

P1476

Q35449751-216F8FA5-3000-49F1-B355-8F11E6D0588C

P2093

Q35449751-043D66DB-6DA5-4844-9220-ADF4521F5784

Q35449751-13186C9D-FCB7-47DE-85E0-B5E1AB9E958A

Q35449751-56AD5350-FEA9-4D52-B747-753C67252606

Q35449751-61A9A48F-3302-4AA6-891A-5AF67053431D

Q35449751-6DFCAB9C-AE04-4EEE-A7C1-DE7D3F6A0CC0

Q35449751-C685D4A5-39EA-4499-B059-4C20AD67D63F

Q35449751-D6CC8B20-5F8A-4ADF-BA11-86F8DC27430A

Q35449751-DCBBD321-DAB8-44F0-9EE4-696DCFCBD244

Q35449751-FB4C63A2-FF43-4DB3-8270-E7A335D8A693

P2860

Q35449751-036A9261-B038-4D1F-85DD-80D177603FA2

Q35449751-08D7C2D8-A1B8-405D-AF82-C59642BB9BDD

Q35449751-09E3C87B-44AA-4BDD-9288-D61ADB1108DD

Q35449751-0D28122F-2B79-4AFE-977F-CD22913E7C23

Q35449751-0E070C6B-3A70-4600-A12D-7777B111F967

Q35449751-0E5DC251-2FC8-4DD4-8481-4CB79AAC6562

Q35449751-1118E15C-7858-4028-B2CD-C8EF82B752C3

Q35449751-13A7038A-50CA-4BEC-B2CE-E47BA13958B3

Q35449751-15570903-E993-4600-8C5E-E37A8955AA89

Q35449751-15F2D0D9-3330-4CD2-9402-C83E0C6F2625

P304

Q35449751-510280AC-2107-434C-9F37-9BF322F45D94

P31

Q35449751-83BF80D8-4F68-4EF4-8D6E-17615848F32F

P356

Q35449751-5CB2DA45-E298-4FA3-A1AA-4AE435EABF87

P433

Q35449751-70AF081E-FF33-4257-9983-CC21FA1F3400

P478

Q35449751-61F5B6C0-CA66-435E-841D-DAA1BFAAA870

P577

Q35449751-D03CF44F-9AB8-4F59-9EB7-FFEDD1531F6B

P698

Q35449751-E8658DF0-13EE-488B-BD17-122AA4A9878B

P932

Q35449751-BBC3D4C8-7262-45A4-A495-4E14790C0EDD

P356

P1433

Brain Pathology

P1476

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up

@en

P2093

Alissa A Caron

http://www.w3.org/2001/XMLSchema#string

Caterina Giannini

http://www.w3.org/2001/XMLSchema#string

Cristiane M Ida

http://www.w3.org/2001/XMLSchema#string

Daniel H Lachance

http://www.w3.org/2001/XMLSchema#string

Dawn L Aranguren

http://www.w3.org/2001/XMLSchema#string

Fausto J Rodriguez

http://www.w3.org/2001/XMLSchema#string

Grant M Spears

http://www.w3.org/2001/XMLSchema#string

Peter C Burger

http://www.w3.org/2001/XMLSchema#string

Sarah M Jenkins

http://www.w3.org/2001/XMLSchema#string

P2860

IDH1 and IDH2 mutations in gliomas

Cerebellar pleomorphic xanthoastrocytoma in an infant.

Pleomorphic xanthoastrocytoma: long-term results of surgical treatment and analysis of prognostic factors.

Pleomorphic xanthoastrocytoma: report of two cases and review of the prognostic factors.

Pediatric cerebellar pleomorphic xanthoastrocytoma with anaplastic features: a case of long-term survival after multimodality therapy.

Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature.

Primary anaplastic pleomorphic xanthoastrocytoma with widespread neuroaxis dissemination at diagnosis--a pediatric case report and review of the literature.

Pigmented pleomorphic xanthoastrocytoma: a rare variant and literature review.

BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications.

Pleomorphic xanthoastrocytoma of the cerebellum.

P304

575-586

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPA.12217

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25318587

http://www.w3.org/2001/XMLSchema#string

P932

4400218

http://www.w3.org/2001/XMLSchema#string